Biochim Biophys Acta. 1979 Feb 26;572(2):269-82. doi: 10.1016/0005-2760(79)90042-0.
PMID:218633
Defective hepatic lipoprotein receptor binding of beta-very low density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E.
Hui DY, Innerarity TL, Mahley RW.
J Biol Chem. 1984 Jan 25;259(2):860-9.
PMID:6319389
Very low density lipoprotein apolipoprotein B metabolism in humans.
Demant T, Shepherd J, Packard CJ.
Klin Wochenschr. 1988 Aug 15;66(16):703-12. doi: 10.1007/BF01726412.
PMID:3050267
Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentration.
Sutherland WH, Janus ED, Nye ER, Grant S.
Biochem Med Metab Biol. 1988 Jun;39(3):305-11. doi: 10.1016/0885-4505(88)90090-4.
PMID:3165001
The double pre-beta very low density lipoprotein lipoproteinemia (DPBL): a new dyslipoproteinemic state.
Pagnan A, Zanetti G, Braggion M, Ziron L, Lusiani L, Visona A, Castellani V, Ronsisvalle G.
Diabete Metab. 1985 Dec;11(6):343-9.
PMID:4085682
Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia.
Dunn FL, Grundy SM, Bilheimer DW, Havel RJ, Raskin P.